It’s easy to become a blood donor. Individuals who are in good health and can meet the general eligibility criteria are likely able to donate. If you were deferred from donating in the past, you may be able to donate again.
As part of our commitment to safety, blood donors must meet certain requirements to give blood. Prior to scheduling an appointment to give blood, review the eligibility requirements and prescreening questions. The guidelines listed below are not all-inclusive and are subject to change.
If you have any questions regarding your eligibility, please contact Bonfils’ Donor Relations department at 303.363.2202 or 800.365.0006, opt. 1.
Weigh at least 115 pounds for whole blood donations or 110 pounds for platelet and plasma donations. Donors weighing over 350 pounds, please call the Appointment Center 303.363.2300 or 800.365.0006, opt. 2, to schedule your appointment at our Lowry or Boulder Community Donor Center locations. Weight requirements may differ depending on the procedure.
Be in good general health with no history of hepatitis or HIV/AIDS.
The donation interval after a whole blood donation is 56 days. Please contact the blood center for the specific interval for other product donations.
Ambulatory Aid For their own safety, donors using any type of temporary ambulatory aids including crutches, canes or other walking aides for a recent injury cannot donate until no longer requiring this assistance. Donors using permanent ambulatory aid may be pre-approved to donate by contacting Bonfils' Donor Relations department at 303.363.2202 or 800.365.0006, opt. 1. Unfortunately, mobile bus programs are unable to accommodate those with walking aides.
Breastfeeding Female donors who are breastfeeding are eligible to donate six weeks after delivery.
Cancer Donor is eligible with a history of basal cell or squamous cell skin cancer or carcinoma in situ (type/size). All other forms of cancer will be assessed at time of donation. Lymphoma and leukemia are currently permanent deferrals.
Colds Donors are not eligible if they are not feeling well and healthy the day of donation.
Diabetes Donors with diabetes (type I or II) are eligible to donate. Diabetics who ever used bovine insulin manufactured in the United Kingdom are deferred.
Heart Disease Donors with a history of heart disease or heart attacks may be eligible to donate provided six months have elapsed from the incident and approval has been obtained from your physician.
Hemochromatosis/Polycythemia Donors diagnosed with hereditary hemochromatosis or polycythemia are asked to contact Bonfils' Donor Relations department at 303.363.2202 or 800.365.0006, opt. 1 to learn more about donation options.
Donor is permanently deferred with a history of hepatitis at age 11 or older
Donor is deferred for 12 months following hepatitis A, hepatitis B or hepatitis C exposure
Hepatitis secondary to a disease process is acceptable
High Blood Presssure Donors with high blood pressure are eligible to donate if their blood pressure is within an acceptable range when taken on the day of donation, regardless of medication.
Malaria Donor is eligible if symptom free for three years.
Pregnant Pregnant donors are not eligible to donate.
Transfusion Donor is deferred for 12 months after a transfusion of blood or blood products.
Travel Donor is deferred for 12 months after travel to a malarial-endemic area. Donor is deferred three years after departure from a malarial-endemic area if he/she is an immigrant, refugee, citizen or resident of the area. Residents are defined as having lived in an area for more than five years. Deferred donor may be eligible to give a research donation.
Most medications are acceptable, the only medications that are NOT APPROVED are:
Antibiotics Given for an active infection Note: Antibiotics given for prophylactic use are acceptable.
Growth hormone from human pituitary glands Used only until 1985, usually for children with delayed or impaired growth
Coumadin (warfarin, Warfilone) Usually given for blood clots in the legs, heart or lungs
Jalyn (dutasteride/tamsulosin) Usually given for prostate enlargement
Pradaxa (dabigatran) Used to reduce the risk of stroke and blood clots
Xarelto® (rivaroxaban) Usually given for post-surgery for hip and knee replacement surgeries
Hepatitis B Immune Globulin Given following an exposure to hepatitis B Note: This is different from the hepatitis B vaccine which is a series of three injections given over a six-month period to prevent future infection from exposures to hepatitis.
Individuals who have had a positive test for HIV/AIDS or who are at risk for contracting HIV/AIDS are permanently deferred from donating blood. Risk factors include:
Use of illegal, street drugs or steroids not prescribed by a doctor, even once
Taking money or drugs for sex since 1977
Male to male sexual contact, even once, since 1977
Ongoing treatment with clotting factor concentrates for hemophilia or similar blood clotting disorders
The following risk factors represent a 12-month deferral for the donor from the date of occurrence:
Intimate/sexual contact with any person in the above categories
Accidental contact with another person's blood/body fluid or an accidental needle stick
Incarceration for more than 72 consecutive hours
Tattoos/Permanent Makeup Donor is eligible if tattooing/makeup application is performed in a physician's office using single-use equipment. Otherwise, donor is deferred for 12 months. Deferred donor may be eligible to give a research donation.
Ear/Body Piercing Donor is eligible if piercing was performed using single-use equipment. Otherwise, donor is deferred for 12 months. Note: Piercings done at Claire's stores and similar establishments are acceptable.
Donor is deferred for travel/residence of three months or more in the United Kingdom from 1980 to 1996. Deferred donor may be eligible to give a research donation.
Extended periods of time in Europe may be a reason for deferral, however donors should speak with a Bonfils representative before they decide not to donate blood. Each case will be assessed at the time of donation or by calling Bonfils' Donor Relations department at 303.363.2202 or 800.365.0006, opt. 1.